Literature DB >> 17664276

Basal activation of p70S6K results in adipose-specific insulin resistance in protein-tyrosine phosphatase 1B -/- mice.

Salvatore C Ruffolo1, Pontus K A Forsell, Xiling Yuan, Sylvie Desmarais, Jean Himms-Hagen, Wanda Cromlish, Kenny K Wong, Brian P Kennedy.   

Abstract

Although protein-tyrosine phosphatase 1B (PTP-1B) is a negative regulator of insulin action, adipose tissue from PTP-1B-/- mice does not show enhanced insulin-stimulated insulin receptor phosphorylation. Investigation of glucose uptake in isolated adipocytes revealed that the adipocytes from PTP-1B-/- mice have a significantly attenuated insulin response as compared with PTP-1B+/+ adipocytes. This insulin resistance manifests in PTP-1B-/- animals older than 16 weeks of age and could be partially rescued by adenoviral expression of PTP-1B in null adipocytes. Examination of adipose signaling pathways found that the basal p70S6K activity was at least 50% higher in adipose from PTP-1B-/- mice compared with wild type animals. The increased basal activity of p70S6K in PTP-1B-/- adipose correlated with decreases in IR substrate-1 protein levels and insulin-stimulated Akt/protein kinase B activity, explaining the decrease in insulin sensitivity even as insulin receptor phosphorylation was unaffected. The insulin resistance of the of the PTP-1B-/- adipocytes could also be rescued by treatment with rapamycin, suggesting that in adipose the loss of PTP-1B results in basal activation of mTOR (mammalian target of rapamycin) complex 1 leading to a tissue-specific insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17664276     DOI: 10.1074/jbc.M700697200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  New emerging role of protein-tyrosine phosphatase 1B in the regulation of glycogen metabolism in basal and TNF-α-induced insulin-resistant conditions in an immortalised muscle cell line isolated from mice.

Authors:  M Alonso-Chamorro; I Nieto-Vazquez; M Montori-Grau; A M Gomez-Foix; S Fernandez-Veledo; M Lorenzo
Journal:  Diabetologia       Date:  2011-02-12       Impact factor: 10.122

2.  Protein Tyrosine Phosphatase 1B (PTP1B) deficiency accelerates hepatic regeneration in mice.

Authors:  Jesús Revuelta-Cervantes; Rafael Mayoral; Soledad Miranda; Agueda González-Rodríguez; Margarita Fernández; Paloma Martín-Sanz; Angela M Valverde
Journal:  Am J Pathol       Date:  2011-03-04       Impact factor: 4.307

3.  Essential role of protein tyrosine phosphatase 1B in obesity-induced inflammation and peripheral insulin resistance during aging.

Authors:  Agueda González-Rodríguez; Jose A Más-Gutierrez; Mercedes Mirasierra; Antonio Fernandez-Pérez; Yong J Lee; Hwi J Ko; Jason K Kim; Eduardo Romanos; Jose M Carrascosa; Manuel Ros; Mario Vallejo; Cristina M Rondinone; Angela M Valverde
Journal:  Aging Cell       Date:  2012-02-01       Impact factor: 9.304

4.  AMPK exerts dual regulatory effects on the PI3K pathway.

Authors:  Rong Tao; Jun Gong; Xixi Luo; Mengwei Zang; Wen Guo; Rong Wen; Zhijun Luo
Journal:  J Mol Signal       Date:  2010-02-18

5.  CNTO 530 functions as a potent EPO mimetic via unique sustained effects on bone marrow proerythroblast pools.

Authors:  Pradeep Sathyanarayana; Estelle Houde; Deborah Marshall; Amy Volk; Dorie Makropoulos; Christine Emerson; Anamika Pradeep; Peter J Bugelski; Don M Wojchowski
Journal:  Blood       Date:  2009-03-05       Impact factor: 22.113

6.  Inhibition of protein tyrosine phosphatase-1B with antisense oligonucleotides improves insulin sensitivity and increases adiponectin concentrations in monkeys.

Authors:  Michael M Swarbrick; Peter J Havel; Arthur A Levin; Andrew A Bremer; Kimber L Stanhope; Madeline Butler; Sheri L Booten; James L Graham; Robert A McKay; Susan F Murray; Lynnetta M Watts; Brett P Monia; Sanjay Bhanot
Journal:  Endocrinology       Date:  2009-01-22       Impact factor: 4.736

7.  Adipocyte-specific protein tyrosine phosphatase 1B deletion increases lipogenesis, adipocyte cell size and is a minor regulator of glucose homeostasis.

Authors:  Carl Owen; Alicja Czopek; Abdelali Agouni; Louise Grant; Robert Judson; Emma K Lees; George D Mcilroy; Olga Göransson; Andy Welch; Kendra K Bence; Barbara B Kahn; Benjamin G Neel; Nimesh Mody; Mirela Delibegović
Journal:  PLoS One       Date:  2012-02-28       Impact factor: 3.240

8.  Profiling the Skeletal Muscle Proteome in Patients on Atypical Antipsychotics and Mood Stabilizers.

Authors:  Kyle J Burghardt; Griffin Calme; Michael Caruso; Bradley H Howlett; Elani Sanders; Zaher Msallaty; Abdullah Mallisho; Berhane Seyoum; Yue A Qi; Xiangmin Zhang; Zhengping Yi
Journal:  Brain Sci       Date:  2022-02-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.